First, we found miR-185 targets DC-SIGN mRNA by binding to the DC-SIGN 3′-UTR to downregulate DC-SIGN expression, which confirmed previous findings that miR-185 regulates gene expression by initiating mRNA degradation and functions as a tumor suppressor [26, 27]. The gene discussed is CD209; the disease is neoplasm.